| Product Code: ETC9974735 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Psoriasis Therapeutics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Psoriasis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Psoriasis Therapeutics Market - Industry Life Cycle |
3.4 United States (US) Psoriasis Therapeutics Market - Porter's Five Forces |
3.5 United States (US) Psoriasis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Psoriasis Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 United States (US) Psoriasis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis in the United States |
4.2.2 Growing awareness and acceptance of advanced psoriasis treatments |
4.2.3 Technological advancements in psoriasis therapeutics |
4.3 Market Restraints |
4.3.1 High cost associated with psoriasis treatments |
4.3.2 Stringent regulatory requirements for approval of new therapies |
4.3.3 Side effects and safety concerns related to certain psoriasis medications |
5 United States (US) Psoriasis Therapeutics Market Trends |
6 United States (US) Psoriasis Therapeutics Market, By Types |
6.1 United States (US) Psoriasis Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Psoriasis Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Psoriasis Therapeutics Market Revenues & Volume, By Plaque Psoriasis, 2021- 2031F |
6.1.4 United States (US) Psoriasis Therapeutics Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2 United States (US) Psoriasis Therapeutics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Psoriasis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United States (US) Psoriasis Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 United States (US) Psoriasis Therapeutics Market Revenues & Volume, By Topical, 2021- 2031F |
7 United States (US) Psoriasis Therapeutics Market Import-Export Trade Statistics |
7.1 United States (US) Psoriasis Therapeutics Market Export to Major Countries |
7.2 United States (US) Psoriasis Therapeutics Market Imports from Major Countries |
8 United States (US) Psoriasis Therapeutics Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed psoriasis treatments |
8.2 Rate of adoption of biologic therapies for psoriasis |
8.3 Number of clinical trials and research studies in the field of psoriasis therapeutics |
8.4 Patient satisfaction with treatment outcomes |
9 United States (US) Psoriasis Therapeutics Market - Opportunity Assessment |
9.1 United States (US) Psoriasis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Psoriasis Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 United States (US) Psoriasis Therapeutics Market - Competitive Landscape |
10.1 United States (US) Psoriasis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Psoriasis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here